# Vincerx Pharma Inc. (VINC)

Source: https://www.quantisnow.com/company/VINC
Generated: 2026-11-12T07:23:41.990Z

- Ticker: VINC
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2025
- Website: vincerx.com

## About

Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops new therapies to address unmet medical needs for the treatment of cancer. The company's lead product candidate is VIP152 that is in Phase I clinical trials to treat solid tumors. Its preclinical stage product candidates include VIP217 for solid tumors; VIP236 to treat multiple solid tumors; VIP943 for the treatment of leukemia and myelodysplastic syndrome; and VIP924 for treating B-cell malignancies. Vincerx Pharma, Inc. was founded in 2019 is based in Palo Alto, California.

## Latest VINC news and filings

- 2025-07-29 21:55 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-vincerx-pharma-inc-6137152)
- 2025-07-16 20:14 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-vincerx-pharma-inc-6122145)
- 2025-07-16 20:05 UTC [Vincerx Pharma, Inc. Announces Additional Adjournment of Special Meeting - Urges Stockholders to Vote FOR Approval of Dissolution Proposal](https://www.quantisnow.com/insight/vincerx-pharma-inc-announces-additional-adjournment-of-special-meeting---6122018)
- 2025-07-07 20:27 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-vincerx-pharma-inc-6112822)
- 2025-07-07 20:23 UTC [SEC Form 8-K] [SEC Form 8-K filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-vincerx-pharma-inc-6112810)
- 2025-07-07 20:05 UTC [Vincerx Pharma, Inc. Urges Stockholders to Vote FOR Approval of Dissolution Proposal and Announces Potential Range for Distributions to Stockholders](https://www.quantisnow.com/insight/vincerx-pharma-inc-urges-stockholders-to-vote-for-approval-of-6112624)
- 2025-06-18 20:18 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-vincerx-pharma-inc-6091936)
- 2025-06-18 20:05 UTC [Vincerx Pharma, Inc. Announces Adjournment of Special Meeting - Will Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal](https://www.quantisnow.com/insight/vincerx-pharma-inc-announces-adjournment-of-special-meeting---will-6091730)
- 2025-06-06 20:01 UTC [SEC Form DEFA14A] [SEC Form DEFA14A filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-defa14a-filed-by-vincerx-pharma-inc-6076080)
- 2025-05-15 20:00 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-vincerx-pharma-inc-6041876)
- 2025-05-15 19:13 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-vincerx-pharma-inc-6041716)
- 2025-05-12 20:49 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-vincerx-pharma-inc-6033668)
- 2025-05-05 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-vincerx-pharma-inc-6016860)
- 2025-05-05 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-vincerx-pharma-inc-6016854)
- 2025-05-05 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-vincerx-pharma-inc-6016848)
- 2025-05-01 21:13 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-vincerx-pharma-inc-6014139)
- 2025-05-01 21:12 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-vincerx-pharma-inc-6014137)
- 2025-05-01 21:11 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-vincerx-pharma-inc-6014131)
- 2025-05-01 21:11 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-vincerx-pharma-inc-6014129)
- 2025-05-01 21:10 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-vincerx-pharma-inc-6014125)
- 2025-05-01 21:08 UTC [SEC Form POS AM filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-vincerx-pharma-inc-6014120)
- 2025-05-01 21:07 UTC [SEC Form POS AM filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-vincerx-pharma-inc-6014116)
- 2025-05-01 21:06 UTC [SEC Form POS AM filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-vincerx-pharma-inc-6014111)
- 2025-04-30 20:41 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-vincerx-pharma-inc-6011032)
- 2025-04-28 20:05 UTC [SEC Form 25 filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-25-filed-by-vincerx-pharma-inc-6004635)
- 2025-04-17 20:52 UTC [SEC Form 8-K] [Vincerx Pharma Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/vincerx-pharma-inc-filed-sec-form-8-k-other-events-5992706)
- 2025-04-17 20:45 UTC [Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC](https://www.quantisnow.com/insight/vincerx-pharma-inc-announces-intent-to-delist-from-nasdaq-and-5992672)
- 2025-04-11 20:03 UTC [SEC Form 8-K] [SEC Form 8-K filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-vincerx-pharma-inc-5985518)
- 2025-04-08 20:05 UTC [Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities](https://www.quantisnow.com/insight/vincerx-pharma-announces-termination-of-letter-of-intent-and-board-5981227)
- 2025-04-03 20:08 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-vincerx-pharma-inc-5975378)
- 2025-04-03 20:01 UTC [SEC Form 424B3] [SEC Form 424B3 filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-424b3-filed-by-vincerx-pharma-inc-5975190)
- 2025-04-03 04:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-vincerx-pharma-inc-5974249)
- 2025-03-31 20:02 UTC [SEC Form S-3] [Amendment: SEC Form S-3/A filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/amendment-sec-form-s-3a-filed-by-vincerx-pharma-inc-5966885)
- 2025-03-27 20:01 UTC [SEC Form 10-K] [SEC Form 10-K filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-10-k-filed-by-vincerx-pharma-inc-5962902)
- 2025-03-18 13:05 UTC [SEC Form 425] [SEC Form 425 filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-425-filed-by-vincerx-pharma-inc-5948978)
- 2025-03-18 13:02 UTC [SEC Form 8-K] [Vincerx Pharma Inc. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/vincerx-pharma-inc-filed-sec-form-8-k-other-events-5948974)
- 2025-03-18 12:52 UTC [Vincerx Pharma Announces Non-Binding Letter of Intent for Business Combination with QumulusAI](https://www.quantisnow.com/insight/vincerx-pharma-announces-non-binding-letter-of-intent-for-business-combination-5948892)
- 2025-02-28 21:10 UTC [SEC Form 8-K] [Vincerx Pharma Inc. filed SEC Form 8-K: Termination of a Material Definitive Agreement, Other Events](https://www.quantisnow.com/insight/vincerx-pharma-inc-filed-sec-form-8-k-termination-of-a-5917339)
- 2025-02-28 21:05 UTC [Vincerx Pharma Announces Termination of Reverse Merger Term Sheet and Evaluation of Strategic Alternatives](https://www.quantisnow.com/insight/vincerx-pharma-announces-termination-of-reverse-merger-term-sheet-and-5917131)
- 2025-02-18 21:03 UTC [SEC Form 8-K] [SEC Form 8-K filed by Vincerx Pharma Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-vincerx-pharma-inc-5893729)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/VINC
- Earnings history: https://www.quantisnow.com/earnings/VINC
- Dividend history: https://www.quantisnow.com/dividends/VINC
- Insider transactions: https://www.quantisnow.com/insiders/VINC
- Options chain: https://www.quantisnow.com/options/VINC
- SEC 8-K filings only: https://www.quantisnow.com/company/VINC/8-k
- RSS and alerts for VINC: https://www.quantisnow.com/docs/rss-feeds.md